Famotidine Dosing for a 4.88 kg Newborn
For this newborn weighing 4.88 kg, administer famotidine 0.25 mg/kg intravenously every 12 hours, which equals approximately 1.2 mg per dose.
Dosing Rationale
The FDA-approved pediatric dosing for famotidine in children 1-16 years is 0.25 mg/kg IV every 12 hours, up to a maximum of 40 mg/day 1. However, critical pharmacokinetic differences exist in infants under 3 months of age that necessitate careful consideration.
Age-Specific Pharmacokinetic Considerations
Infants under 3 months have significantly impaired famotidine clearance:
- Elimination half-life is markedly prolonged (10.51 ± 5.43 hours in neonates vs. 3-4 hours in older children) 2
- Plasma clearance is reduced to 0.132 ± 0.061 L/hr/kg 2
- Renal clearance is decreased compared to infants >3 months 3
Research demonstrates that infants <3 months require **once-daily dosing** rather than every 12 hours due to developmental immaturity in renal function 3. The pharmacokinetic parameters in older infants (>3 months) become similar to children and adults 3.
Recommended Dosing Strategy
Without knowing the exact age of this newborn, I recommend:
If <3 months old:
- 0.25 mg/kg IV once daily (1.2 mg once daily for this 4.88 kg infant)
- Administer over at least 2 minutes or as a 15-minute infusion 1
If >3 months old:
- 0.25 mg/kg IV every 12 hours (1.2 mg every 12 hours)
- Administer over at least 2 minutes or as a 15-minute infusion 1
Clinical Efficacy Data
Studies show that 0.4-0.5 mg/kg IV doses maintain gastric pH >4.0 for approximately 9 hours in children 4. However, a dose of 0.5 mg/kg demonstrated efficacy in reducing regurgitation frequency in infants 5. The lower starting dose of 0.25 mg/kg is recommended by FDA labeling with individualization based on clinical response and gastric pH monitoring 1.
Important Caveats
Common pitfalls to avoid:
- Do not use every 12-hour dosing in infants <3 months - this leads to drug accumulation due to prolonged elimination half-life 3, 2
- Tachyphylaxis occurs with prolonged use - duration of pH elevation decreases significantly after the second dose (14.9 hours after first dose vs. 6.9 hours after second dose) 4
- Monitor for agitation/irritability - this is the most common adverse effect in infants, manifesting as head-rubbing in some cases 5
Administration Details
Preparation:
- Dilute 2 mL of famotidine injection (10 mg/mL) with 0.9% sodium chloride to 5-10 mL total volume
- Inject over minimum 2 minutes, or
- Dilute in 100 mL compatible solution and infuse over 15-30 minutes 1
Recent safety data confirms undiluted IVP administration ≥5 mg is safe in pediatric patients with minimal hemodynamic effects 6, though diluted administration remains standard practice.
Monitoring Requirements
- Gastric pH monitoring is essential to assess treatment effectiveness, particularly with prolonged use 4
- Dose and duration should be individualized based on clinical response and/or pH determination 1
- Watch for decreased efficacy requiring dose adjustment after several days of therapy 4
No pharmacokinetic data exist for infants under 1 month of age 1, making close monitoring particularly important in the youngest neonates.